XM does not provide services to residents of the United States of America.
I
I

IllinoisToolWorks

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

U.S. STOCKS Gold miners , Cytokinetics, Novavax

BUZZ-U.S. STOCKS ON THE MOVE-Gold miners , Cytokinetics, Novavax Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Technology stocks led U.S. indexes higher on Wednesday, as investors strengthened bets for an earlier-than-expected start to the Federal Reserve's policy easing cycle after multiple reports signaled slowing growth in the world's largest economy.
G
I
D
W
U
U
I

U.S. STOCKS Chemours, Hyster-Yale, Guidewire

BUZZ-U.S. STOCKS ON THE MOVE-Chemours, Hyster-Yale, Guidewire Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq edged up on Wednesday as investors strengthened bets for an earlier-than-expected start to the Federal Reserve's easing cycle after multiple reports signaled a weakening labor market and slowing growth in the world's largest economy.
G
I
D
W
U
U
I

J.P. Morgan cuts PT on Illinois Tool Works amid low growth environment

BUZZ-J.P. Morgan cuts PT on Illinois Tool Works amid low growth environment ** Brokerage J.P. Morgan cuts PT for Illinois Tool Works ITW.N to $275 from $280, retains rating "overweight" ** The new price target still represents a 14.26% upside to the stock's last close ** Brokerage says "ongoing lower growth environment led to organic growth guide u
I

U.S. Abbvie, Lionsgate Studios, UnitedHealth Group

U.S. RESEARCH ROUNDUP-Abbvie, Lionsgate Studios, UnitedHealth Group June 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Abbvie, Lionsgate Studios and UnitedHealth Group, on Wednesday. HIGHLIGHTS * Abbvie Inc ABBV.N : HSBC raises to buy from hold * Crowdstrike Holdings Inc CRWD.O : BTIG cuts target price to $402 from $432 * Lionsgate Studios LION.O : Seaport Research Partners initiates coverage with neutral rating
A
S
A
I
L
P

U.S. Honeywell International, Stericycle, Target

U.S. RESEARCH ROUNDUP-Honeywell International, Stericycle, Target June 4 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.listed companies, including Honeywell International, Stericycle and Target Corp on Tuesday. HIGHLIGHTS * Brixmor Property Group Inc BRX.N : Goldman Sachs adds stock to its US conviction list * Honeywell International Inc HON.O : RBC cuts target price to $218 from $222 * Simon Property Group SPG.N : Goldman Sachs removes stock
A
B
I
P

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.